MIGROF 5MG CAPSULE is a combination of Flunarizine and Propranolol which belongs to the group of medicines called Calcium Channel Blockers and Beta-Blockers respectively. It is used as a prophylactic medication for migraine.
It is a recurring type of headache that causes throbbing or pulsating pain on one side of your head which can be of moderate to severe pain. It is generally characterized by symptoms such as nausea, weakness, sensitivity to light and sound.
MIGROF 5MG CAPSULE is not recommended for use in patients having depressive illness, parkinson’s disease (brain disorder), urinary tract obstruction, low blood pressure, diabetes mellitus, liver impairment, second-or third-degree heart block, bronchial asthma.
Before taking MIGROF 5MG CAPSULE inform your doctor if you have signs of thyrotoxicosis (condition marked by increased production of thyroid hormone) such as experiencing unexplained weight loss, irregular heartbeat, feeling shacky and history of allergic reactions.
Along treatment with MIGROF 5MG CAPSULE your doctor might ask you to make some lifestyle changes such as taking adequate sleep, doing regular exercise and eating balanced diet. MIGROF 5MG CAPSULE is not recommended for use in pregnant and breast-feeding women, which is also not recommended for use in children and adolescents (below 18 years of age).
The most common side effects of taking MIGROF 5MG CAPSULE are increase in body weight, increased appetite, blocked or runny nose, problems with sleeping, sleepiness, nausea and constipation. Consult your doctor if any of the side effect worsens.
MIGROF 5MG CAPSULE contains flunarizine and propranolol which helps in preventing migraine, where flunarizine works by dilating the blood vessels in the brain and improving blood flow to the brain by preventing throbbing or pulsating pain on one side of your head and propranolol works by preventing the dilation of blood vessels and stabilizing serotonin levels and it effectively reduces the intensity and frequency of migraine attack.
Take MIGROF 5MG CAPSULE as advised by your doctor. Swallow MIGROF 5MG CAPSULE with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking MIGROF 5MG CAPSULE and consult your doctor immediately if you experience any of the following side effects:
Nausea:
Take MIGROF 5MG CAPSULE with or just after meals. Stick to simple meals. Avoid eating oily or spicy foods. Consult your doctor if your symptom does not improve.
Tiredness:
Drink plenty of fluids and eat balanced diet and frequent meals. Do regular minimal exercise and follow regular sleep schedule. Consult your doctor if your symptom does not improve.
Constipation:
Take fiber rich foods in your diet such as fresh fruits, vegetables, whole grain cereals and drink plenty of fluids. Exercise more regularly and stay active. Consult your doctor if the symptom does not improve.
Diarrhea:
Drink lot of fluids such as water or fruit juice to keep yourself hydrated. Do not take any medicine on your own for treating diarrhoea without consulting your doctor.
Dry mouth:
Try to drink plenty of cold water. Sip on cold unsweetened drinks and use lip balm if your lips are dry. Try to brush your teeth twice a day and use mouthwash. Consult your doctor if the symptom gets worse.
MIGROF 5MG CAPSULE is not recommended for use in pregnant women. Consult your doctor before taking MIGROF 5MG CAPSULE.
MIGROF 5MG CAPSULE is not recommended for use in breastfeeding women. Consult your doctor before taking MIGROF 5MG CAPSULE.
Do not drive or operate any machines if you feel dizzy, drowsy or tired after taking MIGROF 5MG CAPSULE.
Avoid consumption of alcohol while taking MIGROF 5MG CAPSULE as it may cause drowsiness.
MIGROF 5MG CAPSULE should be used with caution in patients with kidney problems. Consult your doctor before taking MIGROF 5MG CAPSULE.
MIGROF 5MG CAPSULE is not recommended for use in patients with liver impairment. It should be used with caution in patients with liver disease such as cirrhosis of the liver. Consult your doctor before taking MIGROF 5MG CAPSULE.
Do not take MIGROF 5MG CAPSULE if you are allergic to Flunarizine and Propranolol.
MIGROF 5MG CAPSULE is not recommended for use in patients having lung diseases such as bronchial asthma, chronic obstructive pulmonary disease (COPD) or any other breathing difficulties. Consult your doctor before taking MIGROF 5MG CAPSULE.
MIGROF 5MG CAPSULE is not recommended for use in patients having heart diseases such as untreated/uncontrolled heart failure, cardiogenic shock, sinus bradycardia, sick sinus syndrome, second- and third-degree heart block, slow heart rate. It should be used with caution in patients having heart weakness, first degree heart block, hypertrophic cardiomyopathy (thickened heart muscle), prinzmetal’s angina (tight, painful feeling in the chest at the time of rest). Consult your doctor before taking MIGROF 5MG CAPSULE.
MIGROF 5MG CAPSULE is not recommended for use if you have:
Before taking MIGROF 5MG CAPSULE, inform your doctor if you have:
Use in Paediatrics:
MIGROF 5MG CAPSULE is not recommended for use in children and adolescents (below 18 years of age). Consult child’s doctor for advice.
Use in Geriatrics:
MIGROF 5MG CAPSULE should be used with caution in elderly patients (aged above 65 years and above) since it may induce depressive illness or parkinson’s disease (brain disorder). Consult your doctor before taking MIGROF 5MG CAPSULE.
A. Drug – Drug interactions:
Before taking MIGROF 5MG CAPSULE, inform your doctor, if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally take too much of MIGROF 5MG CAPSULE, consult your doctor immediately or visit the nearby hospital. Overdosage symptoms of MIGROF 5MG CAPSULE includes sedation, weakness, difficulty breathing, low blood pressure, drowsiness, fits, dilated pupils, an excessively slowed heartbeat with symptoms such as dizziness, sickness, confusion, hallucinations, body spasms, breathlessness on exertion, fainting or coma.
Drug | : | Flunarizine, Propranolol |
Pharmacological Category | : | Calcium Channel Blockers, Beta-Blockers |
Therapeutic Indication | : | Prophylaxis of migraine |
Dosage Forms | : | Tablet, Capsule |
Q: What is MIGROF 5MG CAPSULE and why is it given?
A: MIGROF 5MG CAPSULE is a combination of flunarizine and propranolol which belongs to the group of medicines called calcium channel blockers and beta-blockers respectively, which is used as a prophylactic medication for migraine which is generally characterized by symptoms such as nausea, weakness, sensitivity to light and sound.
Q: Who should avoid taking MIGROF 5MG CAPSULE?
A: MIGROF 5MG CAPSULE is not recommended for use in patients having depressive illness, parkinson’s disease (brain disorder), urinary tract obstruction, low blood pressure, diabetes mellitus, hepatic impairment, second- or third-degree heart block, bronchial asthma, pregnant and breastfeeding women. Consult your doctor before taking MIGROF 5MG CAPSULE.
Q: What are the common side effects of MIGROF 5MG CAPSULE?
A: The most common side-effects of using MIGROF 5MG CAPSULE are increase in body weight, increased appetite, blocked or runny nose, problems with sleeping, sleepiness, nausea and constipation. Consult your doctor if any of these worsens or doesn’t improve.
Q: Does MIGROF 5MG CAPSULE cause weight gain?
A: MIGROF 5MG CAPSULE may cause weight gain when used for longer period of time. Therefore, it is advised to maintain a healthy eating habit and have a balanced diet while taking MIGROF 5MG CAPSULE.
Q: Can MIGROF 5MG CAPSULE be given to children?
A: No, MIGROF 5MG CAPSULE is not recommended for use in children and adolescents (below 18 years of age). If MIGROF 5MG CAPSULE is accidentally ingested by a child or adolescent, go to the hospital immediately and consult the doctor for further management.
1. KD. Tripathi. 5-Hydroxytryptamine, its Antagonists & Drug Therapy of Migraine and Antiarrhythmic Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 180, 532
2. C J Shimell, V U Fritz, S L Levien. A comparative trial of flunarizine and propranolol in the prevention of migraine. NIH. National Library of Medicine. National center for biotechnology information. Pubmed.gov. January 1990. [Accessed on 6th June 2022] https://pubmed.ncbi.nlm.nih.gov/2404346/
3. Mahsa Shahrokhi, Vikas Gupta. Propranolol. NIH. National Library of Medicine. National center for biotechnology information. StatPearls. May 2022. [Accessed on 6th June 2022] https://www.ncbi.nlm.nih.gov/books/NBK557801/
4. H P Ludin. Flunarizine and propranolol in the treatment of migraine. NIH. National Library of Medicine. National center for biotechnology information. Pubmed.gov. April 1989. [Accessed on 6th June 2022] https://pubmed.ncbi.nlm.nih.gov/2654068/
5. Janssen-Cilag S.p.A. Health Products Regulatory Authority (HPRA). [Revised in March 2020]. [Accessed on 6th June 2022] https://www.hpra.ie/img/uploaded/swedocuments/bc725729-1dcc-48c0-b451-a3149ca2f886.pdf
6. Accord Healthcare. Electronic Medicines Compendium (EMC). [Revised in March 2021]. [Accessed on 6th June 2022] https://www.medicines.org.uk/emc/files/pil.5853.pdf
7. Cipla Ltd. Migarid Tablets (Flunarizine hydrochloride). Ciplamed. [Revised in August 2015]. [Accessed on 6th June 2022] https://www.ciplamed.com/content/migarid-tablets
8. Tasmed India Pvt Ltd. Mibeta-Plus Tablet (Propranolol SR 40 mg + Flunarizine 5/10 mg). [Accessed on 6th June 2022] https://tasmedlab.com/allproduct/mibeta-plus/#dosage
Written By Dr. R. Dinesh John Rajkumar, Pharm.D
Last updated on 24 Dec 2022 | 06:01 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.